BioSpace News Archive

Pharm Country

Children’s Hospital of Philadelphia Receives $2 Million Gift to Jump Start New Clinical Trial for Severe Food Allergies

Children’s Hospital of Philadelphia (CHOP) announced today that it has received a philanthropic gift of $2 million from the Mondre and Lane families to launch a new clinical trial at CHOP for patients suffering with severe food allergies.

November 17, 2021
·
3 min read
BioForest

EMulate Therapeutics Announces the Incorporation of Two Wholly Owned Subsidiaries

EMulate Therapeutics Has Incorporated Two Wholly Owned Subsidiaries to Deploy Its Platform Technology for the Treatment of Pain Management and Numerous Mental Health Conditions.

November 17, 2021
·
2 min read
Biotech Beach

Aviva Systems Biology Joins YCharOS, Inc. Industry Advisory Committee to Evaluate Antibody Reagents

Aviva Systems Biology, a market leader in antibodies, immunoassay kits, and recombinant proteins for life science research, today announced it has joined the YCharOS Industry Advisory Committee (IAC) which aims to enable users of antibodies to better evaluate commercially available antibody reagents.

November 17, 2021
·
1 min read
Business

Mount Sinai Spin-Off Linus Biotechnology Inc. to Revolutionize Precision Medicine with Exposome Sequencing

Linus Biotechnology Inc. and Mount Sinai Innovation Partners announced an exclusive worldwide license and collaboration agreement in progress with the Icahn School of Medicine at Mount Sinai, the medical school of the Mount Sinai Health System.

November 17, 2021
·
5 min read
Biotech Bay

Gracell Biotechnologies to Participate in Piper Sandler 33rd Annual Virtual Healthcare Conference

Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), today announced that the management team will participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference.

November 17, 2021
·
1 min read
Biotech Beach

Regen BioPharma, Inc. Announces Signing of a Letter of Intent to Acquire an In vitro Diagnostics Start-Up Company Canary Oncoceutics, Inc. Which is Developing Functional Cancer Tests for Personalized Medicine

Regen BioPharma, Inc. (PINK: RGBP) and (PINK: RGBPP) is currently completing a strategic analysis of its next 5 years of growth.

November 17, 2021
·
4 min read
Deals

HeartBeam Announces Closing of Initial Public Offering

HeartBeam, Inc. (NASDAQ: BEAT), a developmental stage digital healthcare company with a proprietary ECG telemedicine technology to bring new capabilities to cardiovascular disease, today announced the closing of its underwritten initial public offering of 2,750,000 units.

November 17, 2021
·
4 min read
FDA

Avinger Announces FDA Clearance of Pantheris for the Treatment of In-Stent Restenosis

Avinger, Inc. today announced that it has received 510(k) clearance from the U.S. Food & Drug Administration (FDA) for a new clinical indication for the Pantheris image-guided atherectomy system.

November 17, 2021
·
6 min read
Drug Development

Novome Biotechnologies Reports Positive Results from a Phase 1 Study of NOV-001

Novome Biotechnologies, Inc., a clinical-stage biotechnology company developing engineered cellular therapies for the gut, today announced positive results from a Phase 1 study of orally-administered NOV-001 in healthy volunteers.

November 17, 2021
·
5 min read
Deals

Castellum, Inc. Announces Closing of Acquisition of Pax River Business

Castellum, Inc. (OTC: ONOV) announces closing the acquisition of certain key assets located at Patuxent River Naval Air Station (Pax), Maryland from the Albers Group.

November 17, 2021
·
2 min read